获得减肥支持

现在有多种减肥方法可供选择。从改变生活方式(饮食和运动)到药物治疗,不一而足。

遗憾的是,新一类有效的减肥注射剂(GLP1 促效剂,如 Mounjaro 和 Wegovy)在英国国家医疗服务体系(NHS)中只向极少数患者提供。

在本页中,我们将为您提供有关国家医疗服务体系(NHS)和私人提供的各种支持和药物选择的信息。



‍如果您有任何疑问或希望转介,请通过在线咨询/分流工具联系您的全科医生诊所。尽量不要给全科医生诊所打电话,因为在线咨询能更好地处理这些问题。

减肥药物

There are currently 4 different types of weight loss medication available on prescription in the UK. Please note that only very few overweight patients are eligible for weight loss injections on the NHS.

Mounjaro (Tirzepatide)

The most common and most effective weight loss medication used in the UK. Mounjaro is the brand name, whilst Tirzepatide is the name of the ingredient. It is sometimes called Zepbound. 
Medication type: Weekly self-injection
Average weight loss: 20.9% weight loss over 17 months

NHS eligibility:
For white patients: BMI of above 40 with 4 or more serious obesity-related medical conditions
For non-white patients: BMI of above 37.5 with 4 or more serious obesity-related medical conditions
Obesity related medical conditions include high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease (such as history of strokes, heart attacks or angina) , type 2 diabetes 
Requirements will be relaxed slightly in 2026 and 2027.

How to access on the NHS: your GP practice will start to contact you in the coming few months if you are eligible as this new NHS service is rolled out

Private eligibility:
For white patients: BMI of above 30. No other medical conditions needed.
For non-white patients: BMI of above 27.5. No other medical conditions needed.

How to access privately:
Medicspot Weight Loss
Other online pharmacies
Typical private cost £129 to £219 per month 

Note: using private healthcare does not affect your entitlement to present or future NHS care.

Wegovy (Semaglutide)

The first weekly weight loss injection which was available. Wegovy is the brand name, whilst Semaglutide is the ingredient contained within it. Ozempic is the brand of Semaglutide which is used to treat type 2 diabetes.

Medication type: Weekly self-injection
Average weight loss: 14.9% weight loss over 16 months

NHS eligibility:
BMI of above 35 with one serious obesity related medical condition in most NHS areas

How to access on NHS: Generally needs to be prescribed by referral to Tier 3 NHS Weight Management Services (after completion of Tier 2 weight management programme)Long waitlist for Tier 3 services typical

Private eligibility:
For white patients: BMI of above 30. No other medical conditions needed.
For non-white patients: BMI of above 27.5. No other medical conditions needed.

How to access privately:
Online pharmacies
Typical private cost £120 to £270 per month 

Note: using private healthcare does not affect your entitlement to present or future NHS care.

Saxenda (Liraglutide)

The first licensed weight loss injection. Saxenda is the brand name, whilst Liraglutide is the ingredient contained within it. This medication is now seldom used after the launch of the new class of GLP1 agonists (Mounjaro and Wegovy) which have been proven to be more effective. Saxenda is still used occasionally to treat diabetes. 

Medication type: Daily self-injection
Average weight loss: 8.0% weight loss over 12 months

NHS eligibility:
BMI of above 35 with one serious obesity related medical condition in most NHS areas

How to access on NHS:
Not really prescribed much on the NHS
Generally needs to be prescribed by referral to Tier 3 NHS Weight Management Services (after completion of Tier 2 weight management programme)
Long waitlists for Tier 3 services typical

Private eligibility:
For white patients: BMI of above 30. No other medical conditions needed.
For non-white patients: BMI of above 27.5. No other medical conditions needed.

How to access privately:
Online pharmacies
Typical private cost £150 to £300 per month 

Note: using private healthcare does not affect your entitlement to present or future NHS care.

Orlistat (Xenical or Alli)

A tablet which causes a reduction in the amount of fat absorbed by your intestines. Taken three times a day. Alli - a lower dose of Orlistat - can be bought from a pharmacy without a prescription.

Medication type: Daily 3 x daily oral tablet
Average weight loss: 2.9% weight loss over 1-2 years

NHS eligibility:
BMI of above 30

How to access on NHS:
Can be prescribed by your GP

Private eligibility:
For Alli (lower dose) - can buy from pharmacy if BMI of above 28
For prescription (higher dose) - requires BMI of above 30

How to access privately:
Your local pharmacy
Other online pharmacies
Typical private cost £40 to £50 per month 

Note: using private healthcare does not affect your entitlement to present or future NHS care.

Declaration of Interest: Medicspot (Medic Spot Limited) is part of the same financial group as Archvale (Archvale Ltd) - which provides support services to your GP practice operated by the Archvale Partnership. This relationship has no impact on the clinical care you will receive. This declaration is made to ensure transparency, particularly if services or products offered by Medicspot are ever discussed or recommended.

国家医疗服务系统减肥服务

国家医疗服务体系的减肥服务分为四个 "级别"。

第 1
:生活方式建议与教育

申请资格:
向所有人开放

如何获取:

‍NHSBetter Health - Lose Weight- 免费提示、膳食计划、活动建议和一个为期 12 周的减肥应用程序。

‍NHS减肥计划应用程序- 一个为期 12 周的免费计划,可帮助您逐步减轻体重并养成健康的生活习惯

‍NHS体力活动指南- 指导您每周应达到的运动量。

第 2:结构化生活方式计划

免费的社区或数字计划,侧重于饮食、运动和行为改变。当地提供的服务(如 Weightwatchers)取决于您的居住地。包括 NHS 数字化体重管理计划。

申请资格:
‍ 适用于
白人患者:体重指数高于 30 或高于 27.5,且至少有一个与体重相关的医疗问题
对于非白人患者:体重指数高于 27.5 或高于 25 且至少有一个与体重相关的医疗问题

如何获取:
请联系您的药房或全科医生,以便转介至 国民保健服务数字体重管理计划。

‍第
3--专家体重管理服务

由专家(医生、心理学家、营养师)组成的团队与您合作,帮助您减轻体重。

申请资格:
适用于白人患者:体重指数超过 40 或超过 35 且至少有一个与体重相关的医疗问题
对于非白人患者:体重指数高于 37.5 或高于 32.5,且至少有一个与体重相关的医疗问题
注:第 2 级支持必须已尝试至少 6 至 24 个月而未成功。

如何获得:
联系您的全科医生诊所进行转介。


‍Tier4 - Bariatric Surgery Services

适用于严重肥胖或难治性肥胖患者,旨在实施胃旁路手术或胃袖状手术。

申请
资格:
适用于白人患者:体重指数超过 40 或超过 35 且至少有一种与体重相关的疾病
非白人患者:BMI 超过 37.5 或超过 32.5 且至少有一个与体重相关的医疗问题
注:除非 BMI 超过 50 且对健康构成严重威胁,否则必须已完成第 3 级支持

如何获得:
由全科医生或第 3 级支持服务转介。